Literature DB >> 22568886

The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.

Tommy B Andersson1, Kajsa P Kanebratt, John Gerry Kenna.   

Abstract

INTRODUCTION: HepaRG is a unique cell line showing a great plasticity, which differentiates to both canaliculae-like and hepatocyte-like cells. The long-term stability of key cell functions, for example, the drug-metabolizing cytochrome P450 (CYP) enzyme activities, in culture is especially useful in drug metabolism, disposition and toxicity studies. AREAS COVERED: This review describes features of the HepaRG cells focusing on drug-metabolizing enzymes and drug transporters, their functionality and regulation. Several applications in drug discovery studies are discussed and the use of HepaRG, as a human relevant predictive in vitro CYP induction model, is described. In addition, promising studies using HepaRG cells for understanding liver toxicity mechanisms by drug compounds are also discussed. EXPERT OPINION: HepaRG cells exhibit features which make them useful as an in vitro model for drug metabolism, disposition and toxicity studies, and could, for many studies, replace the requirement for primary human hepatocytes. Care should be taken since HepaRG cells are of a specific genotype which is reflected in the expression of drug processing proteins. The finding that HepaRG cells form tight junctions provides the basis for formation of functional canalicular structures and this should be investigated further to aid development of human relevant hepatic in vitro 2D and 3D models.

Entities:  

Mesh:

Year:  2012        PMID: 22568886     DOI: 10.1517/17425255.2012.685159

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  64 in total

1.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

2.  Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.

Authors:  Bryan Mackowiak; Linhao Li; Matthew A Welch; Daochuan Li; Jace W Jones; Scott Heyward; Maureen A Kane; Peter W Swaan; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2017-04-25       Impact factor: 4.436

Review 3.  Cell sources for in vitro human liver cell culture models.

Authors:  Katrin Zeilinger; Nora Freyer; Georg Damm; Daniel Seehofer; Fanny Knöspel
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-05

4.  Hepatitis C Virus Mimics Effects of Glypican-3 on CD81 and Promotes Development of Hepatocellular Carcinomas via Activation of Hippo Pathway in Hepatocytes.

Authors:  Yuhua Xue; Wendy M Mars; William Bowen; Aatur D Singhi; John Stoops; George K Michalopoulos
Journal:  Am J Pathol       Date:  2018-03-22       Impact factor: 4.307

5.  The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies.

Authors:  Liesbeth Ceelen; Marusya Lieveld; Ramses Forsyth; Mathieu Vinken
Journal:  Hepatol Int       Date:  2013-02-14       Impact factor: 6.047

6.  A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Authors:  Anaïs Michaut; Dounia Le Guillou; Caroline Moreau; Simon Bucher; Mitchell R McGill; Sophie Martinais; Thomas Gicquel; Isabelle Morel; Marie-Anne Robin; Hartmut Jaeschke; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

7.  Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells.

Authors:  Klarissa D Hardy; Michelle D Wahlin; Ioannis Papageorgiou; Jashvant D Unadkat; Allan E Rettie; Sidney D Nelson
Journal:  Drug Metab Dispos       Date:  2013-11-04       Impact factor: 3.922

8.  Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures.

Authors:  Jonathan P Jackson; Linhou Li; Erica D Chamberlain; Hongbing Wang; Stephen S Ferguson
Journal:  Drug Metab Dispos       Date:  2016-06-23       Impact factor: 3.922

Review 9.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

10.  A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.

Authors:  Liming Chen; Yifan Bao; Stephanie C Piekos; Kexin Zhu; Lirong Zhang; Xiao-Bo Zhong
Journal:  Mol Pharmacol       Date:  2018-04-24       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.